Bernard L. Kasten, Director at CLEVELAND BIOLABS INC (CBLI), bought 12,000 shares at $6.15 ($74K) on 2010-11-19, disclosed to the SEC on 2010-11-22.
Open-market purchase of $74k CBLI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.10 | 2,000 | $12K | 16.6% |
| 2 | $6.15 | 10,000 | $62K | 83.4% |
| Total | $6.14 avg | 12,000 | $74K | 100% |
| Filing → |
| CBLI | BUY | 2011-08-15 | $26K | — | Filing → |